James Glockner
Overview
Explore the profile of James Glockner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
599
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nayab A, Malik M, Madhavan A, Glockner J, Collins D, Wenger D
Radiol Case Rep
. 2023 Jan;
18(3):1324-1328.
PMID: 36704366
Ganglioneuromas are benign neuroblastic tumors seen most in pediatric population. The most common locations are mediastinal, retroperitoneal and adrenal regions. Ganglioneuromas rarely occur in presacral space. We present one such...
2.
Wallace F, Marell P, Lee N, Glockner J
Mayo Clin Proc
. 2022 Mar;
97(3):571-572.
PMID: 35246287
No abstract available.
3.
Ferguson C, Eirin A, Abumoawad A, Saad A, Jiang K, Hedayat A, et al.
Sci Rep
. 2020 Oct;
10(1):16300.
PMID: 33004888
Tissue fibrosis is an important index of renal disease progression. Diffusion-weighted magnetic resonance imaging's (DWI-MRI) apparent diffusion coefficient (ADC) reveals water diffusion is unobstructed by microstructural alterations like fibrosis. We...
4.
Hogan M, Chamberlin J, Vaughan L, Waits A, Banks C, Leistikow K, et al.
Clin J Am Soc Nephrol
. 2020 Aug;
15(9):1267-1278.
PMID: 32843370
Background And Objectives: We assessed safety and efficacy of another somatostatin receptor analog, pasireotide long-acting release, in severe polycystic liver disease and autosomal dominant polycystic kidney disease. Pasireotide long-acting release,...
5.
Qureshi M, Patterson M, Clark V, Johnson J, Moutvic M, Driscoll S, et al.
J Inherit Metab Dis
. 2020 Jul;
44(2):502-514.
PMID: 32677106
Background: (+)-Epicatechin (EPI) induces mitochondrial biogenesis and antioxidant metabolism in muscle fibers and neurons. We aimed to evaluate safety and efficacy of (+)-EPI in pediatric subjects with Friedreich's ataxia (FRDA)....
6.
Zhu M, Molina J, Dy G, Croghan G, Qi Y, Glockner J, et al.
Invest New Drugs
. 2020 Apr;
38(6):1755-1762.
PMID: 32328844
Purpose Combining small-molecule inhibitors of different targets was shown to be synergistic in preclinical studies. Testing this concept in clinical trials is, however, daunting due to challenges in toxicity management...
7.
Abumoawad A, Saad A, Ferguson C, Eirin A, Herrmann S, Hickson L, et al.
Kidney Int
. 2020 Feb;
97(4):793-804.
PMID: 32093917
Atherosclerotic renovascular disease (ARVD) reduces tissue perfusion and eventually leads to loss of kidney function with limited therapeutic options. Here we describe results of Phase 1a escalating dose clinical trial...
8.
Samreen N, Bhatt A, Glockner J, Lee C
J Clin Imaging Sci
. 2019 Aug;
9:6.
PMID: 31448157
Apparent gadolinium-based contrast enhancement was seen on precontrast-enhanced images on two breast magnetic resonance imaging (MRI) for a patient done 1 week apart. This was caused by ferumoxytol, which is...
9.
Abumoawad A, Saad A, Ferguson C, Eirin A, Woollard J, Herrmann S, et al.
Kidney Int
. 2019 Mar;
95(4):948-957.
PMID: 30904069
The relationships between renal blood flow (RBF), tissue oxygenation, and inflammatory injury in atherosclerotic renovascular disease (ARVD) are poorly understood. We sought to correlate RBF and tissue hypoxia with glomerular...
10.
Bois J, Glockner J, Young P, Foley T, Sheldon S, Newman D, et al.
Open Heart
. 2017 Jan;
4(1):e000546.
PMID: 28123766
Background: Atrial fibrillation (AF) is the most common sustained atrial arrhythmia. One potential target for ablation is left atrial (LA) scar (LAS) regions that may be the substrate for re-entry...